Taxol Is Active in Platinum-Resistant Endometrial Adenocarcinoma

Article Properties
Cite
Woo, H. L., et al. “Taxol Is Active in Platinum-Resistant Endometrial Adenocarcinoma”. American Journal of Clinical Oncology, vol. 19, no. 3, 1996, pp. 290-1, https://doi.org/10.1097/00000421-199606000-00016.
Woo, H. L., Swenerton, K. D., & Hoskins, P. J. (1996). Taxol Is Active in Platinum-Resistant Endometrial Adenocarcinoma. American Journal of Clinical Oncology, 19(3), 290-291. https://doi.org/10.1097/00000421-199606000-00016
Woo HL, Swenerton KD, Hoskins PJ. Taxol Is Active in Platinum-Resistant Endometrial Adenocarcinoma. American Journal of Clinical Oncology. 1996;19(3):290-1.
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Medicine (General)
You May Also Like
Refrences
Title Journal Journal Categories Citations Publication Date
Treatment of Advanced or Recurrent Endometrial Carcinoma with Single-Agent Carboplatin Gynecologic Oncology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Gynecology and obstetrics
  • Medicine
  • Medicine: Medicine (General)
 46 1993
10.1200/JCO.1992.10.11.1748 1992
Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer CancerSpectrum Knowledge Environment
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
 593 1991
10.1016/0090-8258(90)90289-W Gynecologic Oncology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Gynecology and obstetrics
  • Medicine
  • Medicine: Medicine (General)
 1991
Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial Neoplasms Annals of Internal Medicine
  • Medicine: Medicine (General)
  • Medicine: Internal medicine
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 694 1989
Refrences Analysis
Category Category Repetition
Medicine: Medicine (General)7
Medicine4
Medicine: Gynecology and obstetrics3
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens3
Medicine: Internal medicine1
The category Medicine: Medicine (General) 7 is the most frequently represented among the references in this article. It primarily includes studies from Gynecologic Oncology The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Title Journal Journal Categories Citations Publication Date
Paclitaxel Combined with Ticagrelor Inhibits B16F10 and Lewis Lung Carcinoma Cell Metastasis Oncologie
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 1 2022
Comparative Metabolomics Revealed the Potential Antitumor Characteristics of Four Endophytic Fungi of Brassica rapa L. ACS Omega
  • Science: Chemistry
  • Science: Chemistry: General. Including alchemy
  • Science: Chemistry
 12 2020
Sub-acute Toxicity Assessment of Taxol Isolated From Fusarium Solani, an Endophytic Fungus of Taxus Brevifolia, in Wistar Rats and Analyzing Its Cytotoxicity and Apoptotic Potential in Lung Cancer Cells Frontiers in Oncology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 4 2020
Dose dense carboplatin paclitaxel improves progression free survival in patients with endometrial cancer Gynecologic Oncology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Gynecology and obstetrics
  • Medicine
  • Medicine: Medicine (General)
 10 2017
Human CD14+ cells loaded with Paclitaxel inhibit in vitro cell proliferation of glioblastoma Cytotherapy
  • Science: Biology (General): Cytology
  • Technology: Chemical technology: Biotechnology
  • Science: Biology (General): Cytology
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
 12 2015
Citations Analysis
Category Category Repetition
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens96
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system65
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry65
Medicine: Medicine (General)35
Medicine15
Medicine: Gynecology and obstetrics12
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs3
Medicine: Therapeutics. Pharmacology3
Technology: Chemical technology: Biotechnology2
Medicine: Public aspects of medicine: Toxicology. Poisons2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology2
Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine2
Science: Chemistry: General. Including alchemy1
Science: Chemistry1
Science: Biology (General): Cytology1
Science: Biology (General)1
Science: Chemistry: Organic chemistry: Biochemistry1
Science: Microbiology1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system1
The category Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens 96 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Paclitaxel is preferentially cytotoxic to human cervical tumor cells with low Raf-1 kinase activity: implications for paclitaxel-based chemoradiation regimens and was published in 1998. The most recent citation comes from a 2022 study titled Paclitaxel Combined with Ticagrelor Inhibits B16F10 and Lewis Lung Carcinoma Cell Metastasis. This article reached its peak citation in 1999, with 67 citations. It has been cited in 31 different journals, 19% of which are open access. Among related journals, the Neuro-Oncology cited this research the most, with 65 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year